Evidence map›Paper›PMID 37051468›Full record

ArticleFrontiers in cell and developmental biology2023

Myristate induces mitochondrial fragmentation and cardiomyocyte hypertrophy through mitochondrial E3 ubiquitin ligase MUL1.

César Vásquez-Trincado, Mario Navarro-Márquez, Pablo E Morales, Francisco Westermeier, Mario Chiong, Valentina Parra, Alejandra Espinosa, Sergio Lavandero

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

César Vásquez-TrincadoFacultad de Ciencias Químicas y Farmacéuticas y Facultad de Medicina, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.
Mario Navarro-MárquezFacultad de Ciencias Químicas y Farmacéuticas y Facultad de Medicina, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.
Pablo E MoralesFacultad de Ciencias Químicas y Farmacéuticas y Facultad de Medicina, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.
Francisco WestermeierFacultad de Ciencias Químicas y Farmacéuticas y Facultad de Medicina, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.
Mario ChiongFacultad de Ciencias Químicas y Farmacéuticas y Facultad de Medicina, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.
Valentina ParraFacultad de Ciencias Químicas y Farmacéuticas y Facultad de Medicina, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.
Alejandra EspinosaDepartamento de Tecnología Médica, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Sergio LavanderoFacultad de Ciencias Químicas y Farmacéuticas y Facultad de Medicina, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hearthypertrophyinsulin-desensitizationlipotoxicityMAPLmitochondriaMUL1

Identifiers

PMID37051468
PMCPMC10083258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.